BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medical Affairs Professional Society - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://medicalaffairs.org
X-WR-CALDESC:Events for Medical Affairs Professional Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250110T100000
DTEND;TZID=America/New_York:20250110T110000
DTSTAMP:20260422T144221
CREATED:20241204T183136Z
LAST-MODIFIED:20241204T185346Z
UID:50217-1736503200-1736506800@medicalaffairs.org
SUMMARY:Transforming Cancer Detection: The Power of Real-World Evidence and AI in Multi-Cancer Early Detection (MCED) Studies
DESCRIPTION:Join us as we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study. This ambitious initiative aims to enroll 25\,000 patients across diverse backgrounds to evaluate the clinical impact of Multi-Cancer Early Detection (MCED) testing. Discover how this study leverages real-world data and advanced prospective data generation technology to advance MCED technology\, improve patient outcomes\, and reshape the future of cancer care. Learn about the innovative approaches used to assess the effectiveness of MCED tests\, the collaboration with leading health systems\, and the potential to transform early cancer detection globally. \n\n\n\nLearning Objectives: \n\n\n\n\n– Understand the Clinical Impact of MCED Testing: Gain insights into how the Falcon Registry RWE study evaluates Multi-Cancer Early Detection (MCED) testing’s effectiveness across diverse patient populations and its potential to improve early cancer detection and patient outcomes.\n\n\n\n– Explore the Use of Real-World Data (RWD) and Advanced Prospective Data Generation: Learn about the innovative methodologies used to leverage real-world data and advanced prospective data collection technologies to support evidence generation in MCED testing.\n\n\n\n– Identify Strategies for Regulatory Collaboration: Gain insights into collaborative approaches between OM1 and Exact Sciences to align with regulatory expectations\, aiming to advance MCED technology approvals and ensure compliance in global cancer detection initiatives and Real-world data submissions.\n\n\n\n\n \n\n\n\n\nRegister\n\n\n\n\n\n\n\nModerator: \n\n\n\nEric Schrock \n\n\n\nChief Technology Officer and Head of Aspen Solutions \n\n\n\nOM1 \n\n\n\n\n\n\n\nPanelist: \n\n\n\nVijay Parthasarathy \n\n\n\nVice President of Product Management\, Multi-Cancer Early Detection \n\n\n\nExact Sciences \n\n\n\n\n\n\n\nPanelist:  \n\n\n\nRich Gliklich \n\n\n\nCEO \n\n\n\nOM1
URL:https://medicalaffairs.org/events/january10-pcm/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://medicalaffairs.org/wp-content/uploads/2023/04/january-10_PCM.png
END:VEVENT
END:VCALENDAR